Tuberculosis Infection, Latent: Clinical Trials

9 trials for Tuberculosis Infection, Latent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 not yet recruiting, 3 recruiting, 1 enrolling by invitation. 4 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Not yet recruiting 2, Recruiting 2
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Tuberculosis Infection, Latent: new trials by email Literature Review of Tuberculosis Infection, Latent trials Research Report on Tuberculosis Infection, Latent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shaping a Community-based Pathway to Improve TB Surveillance Among African and Hindustan Immigrants Experiencing Vulnerabilities
Tuberculosis, Tuberculosis (TB)
Not yet recruitingUniversidade Nova de Lisboa2002026-12-012026-07-07
Screening With Portable X-rays for Rapid Recognition of TB
Mobile chest radiography for tuberculosis screening - Tuberculosis (TB), Tuberculosis Infection, Latent
Not applicableRecruitingColumbia University10002026-08-252026-10-02
Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan
Tuberculosis, Tuberculosis Infection, Latent
Not yet recruitingPublic Union "Kazakhstan Association of Phthisiopulmonologists"3502026-07-012026-06-25
SCAF-TB - Saving Children and Their Families From Tuberculosis: Implementation Research to Improve TB Preventive Treatment Initiation and Completion Rates Among Contact Persons in Tajikistan and Tanzania
CY-TB Patch, Audiblehealth DX - Tuberculosis Infection, Latent, Tuberculosis Active
Not applicableNot yet recruitingKNCV Tuberculosis Foundation8802026-06-012026-07-20
Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors
Standard isoniazid-based TB/LTBI therapy - Tuberculosis Infection, Tuberculosis Infection, Latent
Not yet recruitingASST Fatebenefratelli Sacco2202026-05-302026-03-16
Burden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-Bissau
Enhanced protocol - Tuberculosis (TB), Tuberculosis Infection, Latent
Not applicableNot yet recruitingAarhus University Hospital7202026-02-012026-02-19
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for 12 weeks, Standard of care tuberculosis prophylaxis with weekly rifapentine and isoniazid for 12 weeks - Tuberculosis Infection, Household Contacts
Not applicableRecruitingPontificia Universidad Catolica de Chile6472025-10-272025-12-29
Shorter and Safer Treatment Regimens for Latent TB
rifampin standard arm, rifampin double dose, levofloxacin and rifapentine - Tuberculosis Infection, Latent
Phase 2 / Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre18002025-06-102026-05-11
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
Latent Tuberculosis Infection, Tuberculosis Infection, Latent
Enrolling by invitationQueen Mary University of London2502024-04-022026-02-20

Narrower conditions

Latent Tuberculosis (9)  ·  Tuberculosis (8)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)

Broader conditions

Actinomycetales Infections (9)  ·  Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Gram-Positive Bacterial Infections (9)  ·  Infections (9)  ·  Latent Infection (9)  ·  Mycobacterium Infections (9)  ·  Blood-Borne Infections (1)  ·  Chemically-Induced Disorders (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)

Interventions

Chemoprevention (1)  ·  Isoniazid (1)  ·  Levofloxacin (1)  ·  rifapentine (1)

Sponsors

ASST Fatebenefratelli Sacco (1)  ·  Aarhus University Hospital (1)  ·  Columbia University (1)  ·  KNCV Tuberculosis Foundation (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  Public Union "Kazakhstan Association of Phthisiopulmonologists" (1)  ·  Queen Mary University of London (1)  ·  Universidade Nova de Lisboa (1)

Countries

Benin (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Guinea-Bissau (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Tajikistan (1)  ·  Tanzania (1)  ·  United Kingdom (1)  ·  United States (1)  ·  Vietnam (1)

Top investigators

Dick Menzies, MD (1)  ·  Ines Fronteira, PhD (1)

Results publications

PMID 36730240

NIH funding

R21AI191193 (1)